Cataracts, a risk of statins?

Take a look at : http://www.medicalnewstoday.com/articles/266445.php The use of statins has been problematic at times, but its benefits are largely clear. If your risk factors for cardiovascular disease are significant, which poses the greater risk, heart attack or cataracts. To me, it's a no brainer;heart attacks have the potential to kill while cataracts, while annoying, are easily treatable. There's rarely a free ride in medicine. You takes your choice. Larry

What are Immune System Disorders

This two page overview will be of value for those who want to understand an increasongly important mechanism of disease. see: http://www.webmd.com/a-to-z-guides/immune-system-disorders?ecd=wnl_day_091913&ctr=wnl-day-091913_ld-stry&mb=UJFQI3JkXVfkt%40jE2DbXMuHnVev1imbCQtc8hErPpek%3d

A Simple Cure two reviews

Just received my second review of my latest novel, A Simple Cure. To say the least, these reviews are beyond my highest aspirations. See: http://www.amazon.com/dp/B00ELWQ4IA

100 Very Cool Facts About The Human Body

More information than you really want to know, but COOL! http://icantseeyou.typepad.com/my_weblog/2008/02/100-very-cool-f.html Larry

New idea for blog

Each day as I read the medical news, I share it with. Dorlis or with others at tennis or racquetball. I've been missing the opportunity to share with readers. This will be much better (& less promotional) than stretching for blog entrees. Will need to workout the logistics first.

What's new?

Just published A Simple Cure:

The novel engages the reader in the search for the cure of malignant melanoma. While an uncommon skin cancer, one American dies of melanoma almost every hour (every 61 minutes). The incidence rate has tripled in the last twenty years.

When nature, in her ultimate act of irony, strikes Richard Powell, a cancer specialist, with malignant melanoma, a highly aggressive form of cancer, his wife, Terri devotes her life to curing the disease that ultimately kills her husband.

While research laboratories are characterized as “noble” in search of cures, and proprietary drug companies are caricatured as ”ruthless and materialistic”, too often, the distinctions aren’t so clear.

The murder of a drug courier to obtain an experimental and promising treatment for malignant melanoma, unleashes a chain of devastating consequences.

People for Alternative Treatment, a company created to find cures for rare diseases, had fallen on hard times and become a subsidiary of Kendall Pharmaceuticals, a company with very different values.

Experimentation with a vaccine against tuberculosis is showing surprising effects in controlling malignant melanoma at PAT and UC Medical Center. Kendall is enthralled with the economic potential of such a treatment, while researchers are leery and have many unanswered questions.

Kendall’s determination to push the vaccine into clinical trial at all costs is in conflict with Terri and her ethical associates.

When clinical trials begin, the vaccine’s effects are miraculous. Soon, however, once again, we see the rule of unintended consequences.

http://www.amazon.com/dp/B00ELWQ4IA

Update website as well.

lawrencewgoldmd.com

Trying ti increase sales

My two newest novels, The Plague Within and Deadly Passage are out and have received excellent reviews.
While I'm grateful for the praise and the sales, the latter, overall, have been modest.
I'm doing what I can through author websites, and at the end of July, and in early August, I'll be offering my novels for free. In the past, free offers have been followed by an increase in sales. These will include No Cure for Murder, Rage, For the Love of God, and The Sixth Sense. Since I have records of my previous month sales, I hope to see a marked increase.
Great sales or not, I continue to enjoy the writing process and the congeniality of fellow writers.

Since I last blogged, I've transferred my website from Yahoo to GoDaddy. The latter offers better tools to create and maintain the site. Take a look at lawrencewgoldmd.com and share your thoughts.

Blogging, I read, is a powerful tool for an author. I'll try to get to it more often.

Larry